ARCHIVES

LAK –IL-2 Studies Continue, Moertel Editorial Blasted

This article is from The Cancer Letter archive.

Vol. 13 No. 11 | March 13, 1987

Download PDF Visit The Full Archive

Related Articles

In Brief: Panel to Meet Jan. 30 In Los Angeles; Fate Of Proposed Urologic Group Depends On Budget

January 10, 1986

Novartis Begins Study Of Femara And Zometa In Postmenopausal Early Breast Cancer

December 27, 2002

NCI-Approved Clinical Trials

July 30, 2004

Gene Patterns Predict Lymphoma Response To Treatment

June 28, 2002

Afatinib Delays Tumor Growth In LUX-Head and Neck 1 Study

October 31, 2014

NCI To File Record No. Of INDS In ’92, Expand Phase 1 Trials

March 6, 1992